Medicine and Dentistry
Cardiovascular System
100%
Coronary Artery Bypass Graft
100%
Patient
90%
Acute Coronary Syndrome
81%
Death
45%
Cardiovascular Disease
36%
Patient History of Coronary Artery Bypass Graft
36%
Statin
27%
Therapeutic Procedure
18%
Evaluation Study
18%
Combination Therapy
18%
Placebo
18%
Lipoprotein
18%
Enalapril Maleate
9%
Myocardial Infarction
9%
Analysis
9%
Cause of Death
9%
Follow up
9%
Risk Reduction
9%
Brain Ischemia
9%
Hazard Ratio
9%
Ischemic Heart Disease
9%
Unstable Angina Pectoris
9%
Nursing and Health Professions
Coronary Artery Bypass Graft
100%
Acute Coronary Syndrome
81%
Death
45%
Cardiovascular Disease
36%
Evaluation Study
18%
Combination Therapy
18%
Confidence Interval
18%
Statin (Protein)
18%
Enalapril Maleate
9%
Heart Infarction
9%
Placebo
9%
Analysis
9%
Hospitalization
9%
Follow up
9%
Cause of Death
9%
Brain Ischemia
9%
Hazard Ratio
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Ischemic Heart Disease
9%
Randomization
9%
Unstable Angina Pectoris
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
81%
Death
45%
Statin (Protein)
18%
Lipoprotein
18%
Enalapril Maleate
9%
Heart Infarction
9%
Ischemic Heart Disease
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Cause of Death
9%
Unstable Angina Pectoris
9%
Brain Ischemia
9%